Carboplatin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Carboplatin Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 04/28/2023. Reported reason: Demand increase for the drug
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 61703-339-18
- Dosage Form
- Injection
- Presentation
- Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18)
- Initial Posting
- 04/28/2023
- Revised Date
Reason
Demand increase for the drug